Abstract:This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).This article has been retracted at the request of the Editor-in-Chief and the authors.Panels from Figure 2A appear similar to panels from Figure 3A of the article published by Xiangyang Dou, Meihua Wang, Tao Zhang and Jiapei Yao in The Anatomical Record (2019) https://doi.org/10.1002/ar.24324, Figures 2B and 6B of the article published by C.-L. Xue, H.-G. Liu, B.-Y. Li, S.-H. He and Q.-F. Yue in the Eur. Rev. Med. Pharmacol. Sci. 23 (2019) 5101-5112 https://doi.org/10.26355/eurrev_201906_18174 and Figure 3B of the article published by Bo Liu and Shuo Yu in Biomedicine & Pharmacotherapy 107 (2018) 243-253 https://doi.org/10.1016/j.biopha.2018.07.177.Panels from Figure 6D appear similar to panels from Figure 8D of the article published by The Anatomical Record (2019) https://doi.org/10.1002/ar.24324, Figure 7E of the article published by Ying Niu, Jinping Zhang, Yalin Tong, Jiansheng Li and Bingrong Liu in Life Sciences 237 (2019) 116893 https://doi.org/10.1016/j.lfs.2019.116893 and Figure 7F of the article published by Xiaoping Pan, Chen Wang, Yan Li, Lida Zhu and Ti Zhang in Life Sciences 214 (2018) 124-135 https://doi.org/10.1016/j.lfs.2018.10.064.Although this article was published earlier than the other articles, the Editor decided to retract this article given concerns about the reliability of the data.

WITHDRAWN: Discovery of a potent inhibitor that suppresses glioblastoma by dual targeting of both syntenin PDZ domains

WITHDRAWN: Dual targeting of mitochondrial Lon peptidase 1 and chymotrypsin-like protease by small molecule BT317, as potential therapeutics in malignant astrocytoma

WITHDRAWN: LonP1 Drives Proneural Mesenchymal Transition in IDH1-R132H Diffuse Glioma

WITHDRAWN: Dual Targeting of Glioma U251 Cells and Neovasculature with a Nanoparticle Encoding Vasohibin and RGD Peptides Prevents Tumor Angiogenesis and Inhibits Tumor Growth

Retinoic acid-incorporated glycol chitosan nanoparticles inhibit the expression of Ezh2 in U118 and U138 human glioma cells

WITHDRAWN: (CA) oligonucleotides correct RNA mis-splicing in TDP-43 pathology

WITHDRAWN: Discovery of 5-benzylidene(thio) barbiturates as a new class of mushroom tyrosinase inhibitors.

Retraction Note: Reprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors

WITHDRAWN: <i>MiR-760</i> inhibits the progression of non-small cell lung cancer through blocking <i> <i>ROS1</i> </i>/Ras/Raf/MEK/ERK pathway

WITHDRAWN: Bioinformatic Analysis of the Roles of CDK2 in Neuroblastoma

Retraction notice to “Design, synthesis, and biological evaluation of heterotetracyclic quinolinone derivatives as anticancer agents targeting topoisomerases” [Eur. J. Med. Chem. 190 (2020) 112074]

WITHDRAWN: An insightful recollection for predicting protein subcellular locations in multi-label systems

Withdrawn: Invisible State of MdmX and Design of its Inhibitors

RETRACTED: Neferine Inhibits Proliferation, Migration and Invasion of U251 Glioma Cells by Down-Regulation of Mir-10B.

WITHDRAWN: ESM1-dependent mesenchymal transition enhances radioresistance of glioblastoma via transcriptional regulation of NFκB.

RETRACTED: Physcion 8-O-β-glucopyranoside Inhibits Clear-Cell Renal Cell Carcinoma Bydownregulating Hexokinase II and Inhibiting Glycolysis.

WITHDRAWN: Progranulin inhibits phospholipase sPLA2-IIA to control neuroinflammation

WITHDRAWN: Advances in the Research of a Novel Mode of the Vascular Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

WITHDRAWN: DiDBiT-TMT: A novel method to quantify changes in the proteomic landscape induced by neural plasticity

WITHDRAWN: A Neurovascular Dual-Targeting Platelet-Like Bioinspired Nanoplatform for Ischemic Stroke Treatment

RETRACTED: Znhit1 Inhibits Breast Cancer by Up-Regulating PTEN to Deactivate the PI3K/Akt/mTOR Pathway